0
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.80.226.90. Please contact the publisher to request reinstatement.
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Psychiatry | 
Original Investigation |  FREE ONLINE FIRST
Jayashri Kulkarni, MBBS, PhD; Emorfia Gavrilidis, BAppSc; Stella M. Gwini, MSc; et al.
JAMA Psychiatry. Published online July 20, 2016. doi:10.1001/jamapsychiatry.2016.1383
Includes: Supplemental Content

JAMA Psychiatry | 
Editorial |  ONLINE FIRST
Jan Volavka, MD, PhD
JAMA Psychiatry. Published online July 13, 2016. doi:10.1001/jamapsychiatry.2016.1348

JAMA Psychiatry | 
Original Investigation |  ONLINE FIRST
Amir Sariaslan, PhD; Paul Lichtenstein, PhD; Henrik Larsson, PhD; et al.
JAMA Psychiatry. Published online July 13, 2016. doi:10.1001/jamapsychiatry.2016.1349
Includes: Supplemental Content

JAMA Psychiatry | 
Original Investigation | 
Elaine H. Morrato, DrPH, MPH; Elizabeth J. Campagna, MS; Sarah E. Brewer, MPA; et al.
JAMA Psychiatry. 2016;73(7):721-730. doi:10.1001/jamapsychiatry.2016.0538.
Includes: Supplemental Content

JAMA Psychiatry | 
Editorial | 
Joseph T. Coyle, MD; Glenn Konopaske, MD
JAMA Psychiatry. 2016;73(7):649-650. doi:10.1001/jamapsychiatry.2016.0575.

JAMA Psychiatry | 
Original Investigation | 
Kate Merritt, MSc; Alice Egerton, PhD; Matthew J. Kempton, PhD; et al.
JAMA Psychiatry. 2016;73(7):665-674. doi:10.1001/jamapsychiatry.2016.0442.
Includes: Supplemental Content

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(23):2514. doi:10.1001/jama.2016.7382.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(23):2514. doi:10.1001/jama.2016.7384.

JAMA Psychiatry | 
Editorial | 
Daphne J. Holt, MD, PhD
JAMA Psychiatry. 2016;73(6):555-556. doi:10.1001/jamapsychiatry.2016.0172.

JAMA Psychiatry | 
Original Investigation | 
Hengyi Cao, MB, MMedSc; Alessandro Bertolino, MD, PhD; Henrik Walter, MD, PhD; et al.
JAMA Psychiatry. 2016;73(6):598-605. doi:10.1001/jamapsychiatry.2016.0161.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Original Investigation  | 
Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women A Randomized Clinical Trial
Jayashri Kulkarni, MBBS, PhD; Emorfia Gavrilidis, BAppSc; Stella M. Gwini, MSc; et al.
JAMA Psychiatry
Editorial  | 
Triggering Violence in Psychosis
Jan Volavka, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Triggers for Violent Criminality in Patients With Psychotic Disorders
Amir Sariaslan, PhD; Paul Lichtenstein, PhD; Henrik Larsson, PhD; et al.
JAMA Psychiatry
Original Investigation  | 
Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics Remaining Barriers to Achieving Population Health Prevention Goals
Elaine H. Morrato, DrPH, MPH; Elizabeth J. Campagna, MS; Sarah E. Brewer, MPA; et al.